Esophageal Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Feb 15, 2003; 9(2): 225-232
Published online Feb 15, 2003. doi: 10.3748/wjg.v9.i2.225
Table 3 Multivariate results in Cox proportional hazards analysis for patients with ESCC
VariablesCategory (Value)βWaldP ValueHR95%CI
Overall survival (n = 106)
location (mid-thoracic)No/Yes (0/l)0.6505.6650.0171.9161.112-3.272
Lymph node metastasisNo/Yes (0/l)0.5995.8930.0151.8211.1222-953
Venous invasionNo/Yes (0/l)1.14718.633< 0.00l3.1481.870-5.229
Clinical stagingI/II/III/IV (0/1/2/3)0.4208.4750.0041.5211.147-2.018
E-cadherin-/ ± /+ (0/1/2)-0.4315.6870.0170.6500.456-0.926
Disease-free survival (n = 96)
GenderM/F (0/1)0.6754.7860.0291.9651.073-3.598
Tumor sizeContinue0.1794.3020.0381.1961.010-1.417
Clinical stagingI/II/III/IV (0/1/2/3)0.2723.2330.0421.3130.976-1.767
Location (mid-thoracic)No/Yes (0/l)0.6154.1110.0431.8491.021-3.349
Venous invasionNo/Yes (0/l)0.9829.7970.0022.6711.444--4.942
E-cadherin-/ ± /+ (0/1/2)-0.3974.4790.0340.6720.465-0.971